These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32081899)

  • 1. A Munc18-1 mutant mimicking phosphorylation by Down Syndrome-related kinase Dyrk1a supports normal synaptic transmission and promotes recovery after intense activity.
    Classen J; Saarloos I; Meijer M; Sullivan PF; Verhage M
    Sci Rep; 2020 Feb; 10(1):3181. PubMed ID: 32081899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of Munc18-1 by Dyrk1A regulates its interaction with Syntaxin 1 and X11α.
    Park JH; Jung MS; Kim YS; Song WJ; Chung SH
    J Neurochem; 2012 Sep; 122(5):1081-91. PubMed ID: 22765017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine phosphorylation of Munc18-1 inhibits synaptic transmission by preventing SNARE assembly.
    Meijer M; Dörr B; Lammertse HC; Blithikioti C; van Weering JR; Toonen RF; Söllner TH; Verhage M
    EMBO J; 2018 Jan; 37(2):300-320. PubMed ID: 29150433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homozygous STXBP1 variant causes encephalopathy and gain-of-function in synaptic transmission.
    Lammertse HCA; van Berkel AA; Iacomino M; Toonen RF; Striano P; Gambardella A; Verhage M; Zara F
    Brain; 2020 Feb; 143(2):441-451. PubMed ID: 31855252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic Short-Term Plasticity Persists in the Absence of PKC Phosphorylation of Munc18-1.
    Wang CC; Weyrer C; Fioravante D; Kaeser PS; Regehr WG
    J Neurosci; 2021 Sep; 41(35):7329-7339. PubMed ID: 34290081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic inhibition upon CB1 or mGlu2/3 receptor activation requires ERK/MAPK phosphorylation of Munc18-1.
    Schmitz SK; King C; Kortleven C; Huson V; Kroon T; Kevenaar JT; Schut D; Saarloos I; Hoetjes JP; de Wit H; Stiedl O; Spijker S; Li KW; Mansvelder HD; Smit AB; Cornelisse LN; Verhage M; Toonen RF
    EMBO J; 2016 Jun; 35(11):1236-50. PubMed ID: 27056679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Munc18-1 expression levels control synapse recovery by regulating readily releasable pool size.
    Toonen RF; Wierda K; Sons MS; de Wit H; Cornelisse LN; Brussaard A; Plomp JJ; Verhage M
    Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18332-7. PubMed ID: 17110441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-linked mutations in Munc18-1 deplete synaptic Doc2.
    Guiberson NGL; Black LS; Haller JE; Brukner A; Abramov D; Ahmad S; Xie YX; Sharma M; Burré J
    Brain; 2024 Jun; 147(6):2185-2202. PubMed ID: 38242640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Form of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A nonphosphorylated at tyrosine 145 and 147 is enriched in the nuclei of astroglial cells, adult hippocampal progenitors, and some cholinergic axon terminals.
    Kida E; Walus M; Jarząbek K; Palminiello S; Albertini G; Rabe A; Hwang YW; Golabek AA
    Neuroscience; 2011 Nov; 195():112-27. PubMed ID: 21878370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of dual specificity kinase activity of DYRK1A.
    Walte A; Rüben K; Birner-Gruenberger R; Preisinger C; Bamberg-Lemper S; Hilz N; Bracher F; Becker W
    FEBS J; 2013 Sep; 280(18):4495-511. PubMed ID: 23809146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Munc18-1 haploinsufficiency impairs learning and memory by reduced synaptic vesicular release in a model of Ohtahara syndrome.
    Orock A; Logan S; Deak F
    Mol Cell Neurosci; 2018 Apr; 88():33-42. PubMed ID: 29217410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Down syndrome candidate dual-specificity tyrosine phosphorylation-regulated kinase 1A phosphorylates the neurodegeneration-related septin 4.
    Sitz JH; Baumgärtel K; Hämmerle B; Papadopoulos C; Hekerman P; Tejedor FJ; Becker W; Lutz B
    Neuroscience; 2008 Dec; 157(3):596-605. PubMed ID: 18938227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synaptic Effects of Munc18-1 Alternative Splicing in Excitatory Hippocampal Neurons.
    Meijer M; Cijsouw T; Toonen RF; Verhage M
    PLoS One; 2015; 10(9):e0138950. PubMed ID: 26407320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1.
    Guo X; Williams JG; Schug TT; Li X
    J Biol Chem; 2010 Apr; 285(17):13223-32. PubMed ID: 20167603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular distribution of cyclin-dependent kinase-like 5 (CDKL5) is regulated through phosphorylation by dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A).
    Oi A; Katayama S; Hatano N; Sugiyama Y; Kameshita I; Sueyoshi N
    Biochem Biophys Res Commun; 2017 Jan; 482(2):239-245. PubMed ID: 27840050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Munc18-1 redistributes in nerve terminals in an activity- and PKC-dependent manner.
    Cijsouw T; Weber JP; Broeke JH; Broek JA; Schut D; Kroon T; Saarloos I; Verhage M; Toonen RF
    J Cell Biol; 2014 Mar; 204(5):759-75. PubMed ID: 24590174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
    Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
    Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Munc13-1 and Munc18-1 together prevent NSF-dependent de-priming of synaptic vesicles.
    He E; Wierda K; van Westen R; Broeke JH; Toonen RF; Cornelisse LN; Verhage M
    Nat Commun; 2017 Jun; 8():15915. PubMed ID: 28635948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
    García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
    Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.